Researchers discover biomarkers that predict lung cancer patient response to therapy

Researchers at UCLA’s Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news120994486.html">Researchers discover biomarkers that predict lung cancer patient response to therapy</a></p> <p>Researchers at UCLA’s Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.</p>